Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Laval University
Collaborators
NCT06605209 · Peripheral Artery Disease (PAD)
NCT06713850 · Peripheral Artery Disease (PAD), Chronic Limb Threatening Ischemia
NCT03304821 · Peripheral Artery Disease (PAD)
NCT02924857 · Peripheral Artery Disease (PAD), Ischemia, and more
NCT07262203 · Peripheral Artery Disease (PAD), Diabetes Mellitus Type 2, and more
CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches
Lévis, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions